This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (54)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Alzheimer Disease  • Alert me on articles by topic  Social Bookmarking   What's this?

Ron Brookmeyer, PhD; Maria M. Corrada, ScM; Frank C. Curriero, PhD; Claudia Kawas, MD

Arch Neurol. 2002;59:1764-1767.

Context  Survival following a diagnosis of Alzheimer disease (AD) is important information for health planners, caregivers, patients, and their families.

Objectives  To estimate the duration of survival following a diagnosis of AD and to determine the effect of AD on life span.

Design, Setting, and Participants  Follow-up of participants of the Baltimore Longitudinal Study of Aging who were older than 55 years (January 1, 1985-September 30, 1999).

Main Outcome Measures  Survival duration.

Results  The median survival time following a diagnosis of AD depended strongly on the patient's age at diagnosis. The median survival times ranged from 8.3 years for persons diagnosed as having AD at age 65 years to 3.4 years for persons diagnosed as having AD at age 90 years. There were no significant differences between men and women in survival after having a diagnosis of AD. Diagnoses of AD at ages 65 and 90 years were associated with approximately a 67% and 39% reduction in median life span, respectively.

Conclusions  The effect of a diagnosis of AD on life span depends crucially on the age of the person when AD is diagnosed. Caregivers, patients, and their families could plan on a median life span as long as 7 to 10 years for patients whose conditions are diagnosed when they are in their 60s and early 70s, to only about 3 years or less for patients whose conditions are diagnosed when they are in their 90s.

From Department of Biostatistics, The Johns Hopkins University Bloomberg School of Public Health (Drs Brookmeyer and Curriero), and the Department of Neurology, The Johns Hopkins University School of Medicine (Ms Corrada and Dr Kawas), Baltimore, Md; and the Institute of Brain Aging and Dementia, University of California, Irvine (Dr Kawas).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

MRI Biomarkers of Vascular Damage and Atrophy Predicting Mortality in a Memory Clinic Population
Henneman et al.
Stroke 2009;40:492-498.
ABSTRACT | FULL TEXT  

Survival in Alzheimer disease: A multiethnic, population-based study of incident cases
Helzner et al.
Neurology 2008;71:1489-1495.
ABSTRACT | FULL TEXT  

Race/ethnic differences in AD survival in US Alzheimer's Disease Centers
Mehta et al.
Neurology 2008;70:1163-1170.
ABSTRACT | FULL TEXT  

Mediterranean diet and Alzheimer disease mortality
Scarmeas et al.
Neurology 2007;69:1084-1093.
ABSTRACT | FULL TEXT  

Survival of Ethnic Chinese With Alzheimer's Disease: A 5-Year Longitudinal Study in Taiwan
Tsai et al.
J Geriatr Psychiatry Neurol 2007;20:172-177.
ABSTRACT  

Terminal Cognitive Decline: Accelerated Loss of Cognition in the Last Years of Life
Wilson et al.
Psychosom. Med. 2007;69:131-137.
ABSTRACT | FULL TEXT  

The GuidAge study: Methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761(R) for prevention of Alzheimer disease in patients over 70 with a memory complaint.
Vellas et al.
Neurology 2006;67:S6-S11.
ABSTRACT | FULL TEXT  

Treating vascular risk factors and maintaining vascular health: Is this the way towards successful cognitive ageing and preventing cognitive decline?
Alagiakrishnan et al.
Postgrad. Med. J. 2006;82:101-105.
ABSTRACT | FULL TEXT  

The staging and assessment of moderate to severe Alzheimer disease
Feldman and Woodward
Neurology 2005;65:S10-S17.
ABSTRACT | FULL TEXT  

Frontotemporal dementia progresses to death faster than Alzheimer disease
Roberson et al.
Neurology 2005;65:719-725.
ABSTRACT | FULL TEXT  

Rate of progression differs in frontotemporal dementia and Alzheimer disease
Rascovsky et al.
Neurology 2005;65:397-403.
ABSTRACT | FULL TEXT  

Sex, Hormones, and Alzheimer's Disease
Baum
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2005;60:736-743.
ABSTRACT | FULL TEXT  

Alzheimer Disease and Mortality: A 15-Year Epidemiological Study
Ganguli et al.
Arch Neurol 2005;62:779-784.
ABSTRACT | FULL TEXT  

Practical Geriatrics: End-of-Life Care for Persons With Alzheimer's Disease
Kim et al.
Psychiatr. Serv. 2005;56:139-141.
FULL TEXT  

The Natural History of Alzheimer Disease: A Longitudinal Presymptomatic and Symptomatic Study of a Familial Cohort
Godbolt et al.
Arch Neurol 2004;61:1743-1748.
ABSTRACT | FULL TEXT  

Dementia: The leading predictor of death in a defined elderly population: The Cache County Study
Tschanz et al.
Neurology 2004;62:1156-1162.
ABSTRACT | FULL TEXT  

Rate of cognitive decline and mortality in Alzheimer's disease
Hui et al.
Neurology 2003;61:1356-1361.
ABSTRACT | FULL TEXT  

OTHER ARTICLES NOTED (24 Jan 03 to 18 Apr 03)
Evid. Based Nurs. 2003;6:e1-12.
FULL TEXT